UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 24, 2017
KINDRED HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)
Delaware | 001-14057 | 61-1323993 | ||
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(IRS Employer Identification No.) |
680 South Fourth Street Louisville, Kentucky |
(Address of principal executive offices) |
40202 |
(Zip Code) |
Registrants telephone number, including area code: (502) 596-7300
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:
❒ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
❒ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
❒ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
❒ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ❒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ❒
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On May 24, 2017, Thomas P. Cooper, M.D. retired from the Board of Directors (the Board) of Kindred Healthcare, Inc. (the Company). Dr. Coopers term on the Board expired upon the conclusion of the Companys 2017 annual meeting of shareholders (the Annual Meeting).
Item 5.07. Submission of Matters to a Vote of Security Holders.
At the Annual Meeting, the Companys shareholders voted to elect the following board members to terms expiring at the Companys 2018 Annual Meeting of Shareholders: Joel Ackerman, Jonathan D. Blum, Benjamin A. Breier, Paul J. Diaz, Heyward R. Donigan, Richard Goodman, Christopher T. Hjelm, Frederick J. Kleisner, Sharad Mansukani, M.D., Lynn Simon, M.D. and Phyllis R. Yale.
In addition to electing directors, the Companys shareholders voted to approve the Companys executive compensation program and an annual advisory vote with respect to compensation of the Companys named executive officers. The Companys shareholders also approved the Kindred Healthcare, Inc. Stock Incentive Plan, Amended and Restated; the Kindred Healthcare, Inc. Equity Plan for Non-Employee Directors, Amended and Restated; and ratified the appointment of PricewaterhouseCoopers LLP as the Companys independent registered public accounting firm for fiscal year 2017.
The final voting results on these matters were as follows:
1. | Election of Directors: |
Name |
For | Against | Abstain | Broker Non-Votes |
||||||||||||
a. Joel Ackerman |
65,392,335 | 792,473 | 23,900 | 12,279,261 | ||||||||||||
b. Jonathan D. Blum |
65,391,346 | 792,273 | 25,089 | 12,279,261 | ||||||||||||
c. Benjamin A. Breier |
65,140,716 | 1,043,259 | 24,733 | 12,279,261 | ||||||||||||
d. Paul J. Diaz |
65,115,153 | 1,068,666 | 24,889 | 12,279,261 | ||||||||||||
e. Heyward R. Donigan |
65,397,509 | 787,301 | 23,898 | 12,279,261 | ||||||||||||
f. Richard Goodman |
65,400,708 | 783,450 | 24,550 | 12,279,261 | ||||||||||||
g. Christopher T. Hjelm |
65,381,837 | 801,573 | 25,298 | 12,279,261 | ||||||||||||
h. Frederick J. Kleisner |
65,335,345 | 848,810 | 24,553 | 12,279,261 | ||||||||||||
i. Sharad Mansukani, M.D. |
65,385,255 | 799,667 | 23,786 | 12,279,261 | ||||||||||||
j. Lynn Simon, M.D. |
65,674,387 | 509,105 | 25,216 | 12,279,261 | ||||||||||||
k. Phyllis R. Yale |
65,071,304 | 1,112,650 | 24,754 | 12,279,261 |
2. | Non-binding advisory vote to approve the compensation of the Companys named executive officers disclosed in the Companys 2017 Proxy Statement: |
For | Against | Abstain | Broker Non-Votes | |||
61,800,396 | 4,334,714 | 73,598 | 12,279,261 |
3. | Non-binding advisory vote on the frequency of the advisory vote to approve the compensation of the Companys named executive officers: |
One Year | Two Years | Three Years | Abstain | |||
50,349,142 | 81,076 | 15,727,699 | 50,791 |
4. | Proposal to approve the Kindred Healthcare, Inc. Stock Incentive Plan, Amended and Restated: |
For | Against | Abstain | Broker Non-Votes | |||
64,269,814 | 1,867,688 | 71,206 | 12,279,261 |
5. | Proposal to approve the Kindred Healthcare, Inc. Equity Plan for Non-Employee Directors, Amended and Restated: |
For | Against | Abstain | Broker Non-Votes | |||
56,867,755 | 8,116,662 | 1,224,291 | 12,279,261 |
6. | Proposal to ratify the appointment of PricewaterhouseCoopers, LLP as the Companys independent registered public accounting firm for fiscal year 2017: |
For | Against | Abstain | ||
77,807,928 | 591,477 | 88,564 |
Item 8.01. Other Events.
Incorporated by reference is a press release issued by the Company on May 24, 2017 announcing the vote results from the Annual Meeting, which is attached hereto as Exhibit 99.1.
Item 9.01. Exhibits.
(d) | Exhibits |
Exhibit |
Description | |
99.1 | Press release dated May 24, 2017. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereto duly authorized.
KINDRED HEALTHCARE, INC. | ||||||
Date: May 25, 2017 | By: | /s/ Joseph L. Landenwich | ||||
Joseph L. Landenwich | ||||||
General Counsel and Corporate Secretary |
EXHIBIT INDEX
Exhibit |
Description | |
99.1 | Press release dated May 24, 2017. |
EXHIBIT 99.1 |
Contact: | Todd Flowers |
Investor Relations
(502) 596-6569
KINDRED HEALTHCARE ANNOUNCES VOTING RESULTS
FOR THE 2017 ANNUAL MEETING OF SHAREHOLDERS
LOUISVILLE, Ky. (May 24, 2017) Kindred Healthcare, Inc. (Kindred or the Company) (NYSE:KND) today announced the voting results of the Companys 2017 Annual Meeting of Shareholders held on May 24, 2017.
At the annual meeting, the Companys shareholders voted to elect the following board members to terms expiring at the Companys 2018 Annual Meeting of Shareholders: Joel Ackerman, Jonathan D. Blum, Benjamin A. Breier, Paul J. Diaz, Heyward R. Donigan, Richard Goodman, Christopher T. Hjelm, Frederick J. Kleisner, Sharad Mansukani, M.D., Lynn Simon, M.D., and Phyllis R. Yale.
In addition to electing directors, the Companys shareholders voted to approve the Companys executive compensation program and an annual advisory vote with respect to compensation of the Companys named executive officers. The Companys shareholders also approved the Kindred Healthcare, Inc. Stock Incentive Plan, Amended and Restated; the Kindred Healthcare, Inc. Equity Plan for Non-Employee Directors, Amended and Restated; and ratified the appointment of PricewaterhouseCoopers LLP as the Companys independent registered public accounting firm for fiscal year 2017.
About Kindred Healthcare
Kindred Healthcare, Inc., a top-90 private employer in the United States, is a FORTUNE 500 healthcare services company based in Louisville, Kentucky with annual revenues of approximately $7.2 billion(1). At March 31, 2017, Kindred through its subsidiaries had approximately 100,100 employees providing healthcare services in 2,624 locations in 46 states, including 82 LTAC hospitals, 19 inpatient rehabilitation hospitals, 91 nursing centers, 19 sub-acute units, 619 Kindred at Home home health, hospice and non-medical home care sites of service, 101 inpatient rehabilitation units (hospital-based) and contract rehabilitation service businesses which served 1,693 non-affiliated sites of service. Ranked as one of Fortune magazines Most Admired Healthcare Companies for eight years, Kindreds mission is to promote healing, provide hope, preserve dignity and produce value for each patient, resident, family member, customer, employee and shareholder we serve. For more information, go to www.kindredhealthcare.com. You can also follow us on Twitter and Facebook.
(1) | Revenues for the last twelve months ended March 31, 2017. |
- END -
680 South Fourth Street Louisville, Kentucky 40202
502.596.7300 www.kindredhealthcare.com